TherapeuticsMD reported 0.75 in PE Price to Earnings for its fiscal quarter ending in March of 2023.





Pe Change Date
AbbVie 23.03 1 Mar/2026
Cipla 35.82 12.26 Jun/2026
Clal Biotechnology 11.67 2.62 Dec/2022
Compugen 5.45 1.39 Mar/2026
CSL 16.16 9.59 Dec/2025
Grifols 11.2 1.08 Dec/2025
Novo Nordisk 13.92 4.91 Sep/2025
Pfizer 9.32 5.16 Mar/2026
TherapeuticsMD 0.75 3.3 Mar/2023